Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
AUTOR(ES)
D'Antonio, R G
RESUMO
Daily administration of 1 mg of folinic acid to immunosuppressed rats with incipient or established Pneumocystis carinii pneumonia did not impair the capacity of trimethoprim-sulfamethoxazole to either prevent or treat this disease. These observations constitute the first experimental support for the use of folinic acid to prevent or control cytopenias that occur in patients with Pneumocystis carinii pneumonia who are under trimethoprim-sulfamethoxazole treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176401Documentos Relacionados
- Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.
- Combination of Pentamidine and Trimethoprim-Sulfamethoxazole in the Therapy of Pneumocystis carinii Pneumonia in Rats
- Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.
- Low-dose trimethoprim-sulfamethoxazole alone and in association with zidovudine for prevention and treatment of murine Pneumocystis carinii pneumonia.
- Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
